Oramed Pharmaceuticals Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2024 Annual Meeting of Stockholders held by Oramed Pharmaceuticals Inc. on August 1, 2024. The company is incorporated in Delaware and trades on the Nasdaq Capital Market and Tel Aviv Stock Exchange under the symbol ORMP.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on three proposals at the annual meeting:
- Proposal 1 (Re-election of Directors): All seven nominees were re-elected. Notable voting statistics include:
- Dr. Daniel Aghion: 10,090,486 For, 117,471 Against.
- Dr. Miriam Kidron: 10,011,623 For, 211,627 Against.
- Nadav Kidron: 10,007,284 For, 216,146 Against.
- Dr. Arie Mayer: 9,688,466 For, 529,929 Against.
- Yehuda Reznick: 10,050,385 For, 138,618 Against.
- Leonard Sank: 9,435,858 For, 764,562 Against.
- Benjamin Shapiro: 10,120,322 For, 112,399 Against.
- Proposal 2 (Advisory Vote on Executive Compensation): Approved by stockholders. Votes: 9,171,779 For, 1,016,334 Against, 74,388 Abstain.
- Proposal 3 (Ratification of Auditors): Ratified the appointment of Kesselman & Kesselman (a member of PricewaterhouseCoopers International Limited). Votes: 17,323,361 For, 119,546 Against, 56,334 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the standard disclosure of voting results.
Key Facts for Investor Verification
- Verify the total number of shares entitled to vote versus the number of shares actually voted to assess participation rates.
- Review the proxy statement for details on the executive compensation package approved in Proposal 2.
- Confirm the tenure and specific roles of the re-elected directors, particularly those with higher "Against" vote counts (e.g., Leonard Sank and Dr. Arie Mayer).
- Check subsequent filings for the company's financial performance, as this 8-K contains no financial data.